Introduction: Endometrial cancer is the most common gynaecological cancer and its
incidence is rising due to increasing obesity rates. We are also seeing an increasing trend of …

The human endometrium is a unique tissue undergoing important changes through the
menstrual cycle. Under the exposure of different risk factors in a woman's lifetime, normal …

Despite the improvement in overall survival for ovarian cancer (OC) patients, a fraction of
patients with advanced-stage disease fails to respond to primary therapy and relapses in …

Introduction Endometrial cancer, one of the most frequent pelvic gynecologic cancer
worldwide, currently has no biomarker used to assess it in daily practice. Nonetheless …

Objective: To date, biomarkers are not routinely used in endometrial cancer diagnosis,
prognosis, and follow-up. The purpose of this study was to evaluate whether serum HE4 was …

Background The purpose of this study was to evaluate serum HE4 as a biomarker to detect
recurrent disease during follow-up of patients with endometrial adenocarcinoma (EAC) …

Objective To evaluate the predictive value of serum HE 4 and CA 125 concentrations in the
preoperative prediction of risk of lymph node metastasis in endometrial cancer. Methods A …

Background Endometrial cancer (EC) is a common female malignant cancer. The age of
incidence has become younger than before. If the diagnosis is during stage I, then the …

Endometrial cancer is the most common genital cancer in high‐resource countries.
Treatment is essentially surgical, but the role of lymphadenectomy in the treatment of low …

The aim of this study was to evaluate for the first time in the literature the role of HE4, at
primary diagnosis, compared to CA125 as an indicator of endometrial cancer (EC) …